Across 31 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Baker Bros. Advisors Lp, Board Member / Investor Representative. Insider active across 28 companies, notably Seagen Inc.. Cumulatively, 306 filings have been logged. Split: 177 buys · 16 sells. Total volume traded: €750.8m. Activity tracked since 14 May 2021. The latest transaction was disclosed on 22 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 306 declarations
BAKER BROS. ADVISORS LP is a declarant whose primary role is Board Member / Investor Representative. It has 304 filings in total, and in the recent sampled filings of 304, the reported volumes are EUR 84,231,102 of buys and EUR 392,439,650 of sells, over the period from 2016-01-08 to 2026-07-02. The associated companies are Madrigal Pharmaceuticals, INC. as Director, AQUINOX PHARMACEUTICALS, INC as 10% Owner, INCYTE CORP as Director, BeiGene, Ltd. as Director, IGM Biosciences, Inc. with no role indicated, and BICYCLE THERAPEUTICS plc as Director.